Cargando…
Macrophages as a Therapeutic Target in Metastatic Prostate Cancer: A Way to Overcome Immunotherapy Resistance?
SIMPLE SUMMARY: In recent years, therapeutic options for patients with metastatic prostate cancer have improved significantly. However, the efficacy of current immunotherapy strategies in metastatic prostate cancer patients is limited. The prostate cancer tumor microenvironment, which includes immun...
Autores principales: | Martori, Clara, Sanchez-Moral, Lidia, Paul, Tony, Pardo, Juan Carlos, Font, Albert, Ruiz de Porras, Vicenç, Sarrias, Maria-Rosa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773572/ https://www.ncbi.nlm.nih.gov/pubmed/35053602 http://dx.doi.org/10.3390/cancers14020440 |
Ejemplares similares
-
Immune Checkpoint Inhibitors: A Promising Treatment Option for Metastatic Castration-Resistant Prostate Cancer?
por: Ruiz de Porras, Vicenç, et al.
Publicado: (2021) -
Multifaceted Roles of CD5L in Infectious and Sterile Inflammation
por: Sanchez-Moral, Lidia, et al.
Publicado: (2021) -
Macrophage CD5L is a target for cancer immunotherapy
por: Sanchez-Moral, Lidia, et al.
Publicado: (2023) -
Lipid Metabolism and Epigenetics Crosstalk in Prostate Cancer
por: Pardo, Juan C., et al.
Publicado: (2022) -
Molecular Mechanisms of Tumor Progression and New Therapeutic Strategies for Urological Cancers
por: Ruiz de Porras, Vicenç, et al.
Publicado: (2023)